Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Silicon photodiodes with high photoconductive gain at room temperature.

Li X, Carey JE, Sickler JW, Pralle MU, Palsule C, Vineis CJ.

Opt Express. 2012 Feb 27;20(5):5518-23. doi: 10.1364/OE.20.005518.

PMID:
22418357
2.

High-density regular arrays of nanometer-scale rods formed on silicon surfaces via femtosecond laser irradiation in water.

Shen M, Carey JE, Crouch CH, Kandyla M, Stone HA, Mazur E.

Nano Lett. 2008 Jul;8(7):2087-91. doi: 10.1021/nl080291q. Epub 2008 Jun 10.

PMID:
18540658
3.

Enhancing near-infrared avalanche photodiode performance by femtosecond laser microstructuring.

Myers RA, Farrell R, Karger AM, Carey JE, Mazur E.

Appl Opt. 2006 Dec 10;45(35):8825-31.

PMID:
17119579
4.

Superhydrophobic surfaces prepared by microstructuring of silicon using a femtosecond laser.

Baldacchini T, Carey JE, Zhou M, Mazur E.

Langmuir. 2006 May 23;22(11):4917-9.

PMID:
16700574
5.

Visible and near-infrared responsivity of femtosecond-laser microstructured silicon photodiodes.

Carey JE, Crouch CH, Shen M, Mazur E.

Opt Lett. 2005 Jul 15;30(14):1773-5.

PMID:
16092341
6.

Thyroid carcinoma with high levels of function: treatment with (131)I.

Sisson JC, Carey JE.

J Nucl Med. 2001 Jun;42(6):975-83.

7.

Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction.

Bowen WP, Carey JE, Miah A, McMurray HF, Munday PW, James RS, Coleman RA, Brown AM.

Drug Metab Dispos. 2000 Jul;28(7):781-8.

PMID:
10859152
8.

In vivo biodistribution of 125IPIP and internal dosimetry of 123IPIP radioiodinated agents selective to the muscarinic acetylcholinergic receptor complex.

Breeden WK 3rd, Hamby DM, Carey JE Jr, Eckerman KF, McPherson DW, Knapp FF Jr.

Med Phys. 2000 Apr;27(4):778-86.

9.

[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses.

Mulholland GK, Wieland DM, Kilbourn MR, Frey KA, Sherman PS, Carey JE, Kuhl DE.

Synapse. 1998 Nov;30(3):263-74.

10.

Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy.

Gates VL, Carey JE, Siegel JA, Kaminski MS, Wahl RL.

J Nucl Med. 1998 Jul;39(7):1230-6.

11.

Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine?

Sisson JC, Jamadar DA, Kazerooni EA, Giordano TJ, Carey JE, Spaulding SA.

Thyroid. 1998 Mar;8(3):215-21.

PMID:
9545107
12.

Simplifying the dosimetry of carbon-11-labeled radiopharmaceuticals.

Wrobel MC, Carey JE, Sherman PS, Kilbourn MR.

J Nucl Med. 1997 Apr;38(4):654-60.

13.

Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.

Newton RA, Phipps SL, Flanigan TP, Newberry NR, Carey JE, Kumar C, McDonald B, Chen C, Elliott JM.

J Neurochem. 1996 Dec;67(6):2521-31.

PMID:
8931486
14.

Characterization of the 5-hydroxytryptamine2A receptor-activated cascade in rat C6 glioma cells.

Elliott JM, Newberry NR, Cholewinski AJ, Bartrup JT, Briddon SJ, Carey JE, Flanigan TP, Newton RA, Phipps SL, Reavley AC, et al.

Neuroscience. 1995 Dec;69(4):1119-31.

PMID:
8848101
15.

In vivo imaging of the brain vesicular monoamine transporter.

Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, Frey KA.

J Nucl Med. 1995 Dec;36(12):2252-60.

16.

Laparoscopy and thoracoscopy in evaluation of abdominal trauma.

Carey JE, Koo R, Miller R, Stein M.

Am Surg. 1995 Jan;61(1):92-5.

PMID:
7832391
17.

Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist.

Mulholland GK, Kilbourn MR, Sherman P, Carey JE, Frey KA, Koeppe RA, Kuhl DE.

Nucl Med Biol. 1995 Jan;22(1):13-7.

PMID:
7735163
18.

In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM.

Kuhl DE, Koeppe RA, Fessler JA, Minoshima S, Ackermann RJ, Carey JE, Gildersleeve DL, Frey KA, Wieland DM.

J Nucl Med. 1994 Mar;35(3):405-10.

19.

Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter.

DaSilva JN, Carey JE, Sherman PS, Pisani TJ, Kilbourn MR.

Nucl Med Biol. 1994 Feb;21(2):151-6.

20.

Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.

Sisson JC, Shapiro B, Hutchinson RJ, Carey JE, Zasadny KR, Zempel SA, Normolle DP.

Eur J Nucl Med. 1994 Jan;21(1):46-52.

21.

Radiation protection design for a clinical positron emission tomography imaging suite.

Kearfott KJ, Carey JE, Clemenshaw MN, Faulkner DB.

Health Phys. 1992 Nov;63(5):581-9.

PMID:
1399646
22.

A recombinant, chimeric enzyme with a novel mechanism of action leading to greater potency and selectivity than tissue-type plasminogen activator.

Robinson JH, Browne MJ, Carey JE, Chamberlain PD, Chapman CG, Cronk DW, Dodd I, Entwisle C, Esmail AF, Kalindjian SB, et al.

Circulation. 1992 Aug;86(2):548-52.

PMID:
1638720
23.

131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.

Hutchinson RJ, Sisson JC, Shapiro B, Miser JS, Normole D, Shulkin BL, Francis IR, Zasadny K, Carey JE, Johnson JW, et al.

Am J Clin Oncol. 1992 Jun;15(3):226-32.

PMID:
1590275
24.

Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent.

Mulholland GK, Otto CA, Jewett DM, Kilbourn MR, Koeppe RA, Sherman PS, Petry NA, Carey JE, Atkinson ER, Archer S, et al.

J Nucl Med. 1992 Mar;33(3):423-30. Erratum in: J Nucl Med 1992 May;33(5):667.

25.

In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography.

Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RL, Carey JE, Wieland DM, Kuhl DE, Agranoff BW.

J Cereb Blood Flow Metab. 1992 Jan;12(1):147-54.

PMID:
1727135
26.

Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.

Shapiro B, Sisson JC, Wieland DM, Mangner TJ, Zempel SM, Mudgett E, Gross MD, Carey JE, Zasadny KR, Beierwaltes WH.

J Nucl Biol Med. 1991 Oct-Dec;35(4):269-76.

PMID:
1823834
27.

Cerebral blood flow mapping using stable xenon-enhanced CT in sickle cell cerebrovascular disease.

Numaguchi Y, Haller JS, Humbert JR, Robinson AE, Lindstrom WW, Gruenauer LM, Carey JE.

Neuroradiology. 1990;32(4):289-95.

PMID:
2234387
28.

Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo.

Kilbourn MR, Carey JE, Koeppe RA, Haka MS, Hutchins GD, Sherman PS, Kuhl DE.

Int J Rad Appl Instrum B. 1989;16(6):569-76.

29.

A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain.

Browne MJ, Carey JE, Chapman CG, Tyrrell AW, Entwisle C, Lawrence GM, Reavy B, Dodd I, Esmail A, Robinson JH.

J Biol Chem. 1988 Feb 5;263(4):1599-602.

30.

Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.

Sisson JC, Hutchinson RJ, Carey JE, Shapiro B, Johnson JW, Mallette SA, Wieland DM.

Eur J Nucl Med. 1988;14(7-8):337-40.

31.

Quantitative organ visualization using SPECT.

Kircos LT, Carey JE Jr, Keyes JW Jr.

J Nucl Med. 1987 Mar;28(3):334-41.

32.

Determination of iodine-131 diagnostic dose for imaging metastatic thyroid cancer.

Arnstein NB, Carey JE, Spaulding SA, Sisson JC.

J Nucl Med. 1986 Nov;27(11):1764-9.

33.

Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans.

Koral KF, Adler RS, Carey JE, Beierwaltes WH.

J Nucl Med. 1986 Jul;27(7):1207-11.

34.

Phosphorus-32 therapy of cystic Grade IV astrocytomas: technique and preliminary application.

Taasan V, Shapiro B, Taren JA, Beierwaltes WH, McKeever P, Wahl RL, Carey JE, Petry N, Mallette S.

J Nucl Med. 1985 Nov;26(11):1335-8.

35.

Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.

Browne MJ, Dodd I, Carey JE, Chapman CG, Robinson JH.

Thromb Haemost. 1985 Aug 30;54(2):422-4.

PMID:
3936214
36.

Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cells.

Browne MJ, Tyrrell AW, Chapman CG, Carey JE, Glover DM, Grosveld FG, Dodd I, Robinson JH.

Gene. 1985;33(3):279-84.

PMID:
3839198
37.

Radiopharmaceutical treatment of malignant pheochromocytoma.

Sisson JC, Shapiro B, Beierwaltes WH, Glowniak JV, Nakajo M, Mangner TJ, Carey JE, Swanson DP, Copp JE, Satterlee WG, et al.

J Nucl Med. 1984 Feb;25(2):197-206.

38.

Treatment of malignant pheochromocytoma with a new radiopharmaceutical.

Sisson J, Shapiro B, Beierwaltes WH, Nakajo M, Glowniak J, Mangner T, Carey JE, Swanson DP, Copp J, Satterlee W, et al.

Trans Assoc Am Physicians. 1983;96:209-17.

PMID:
6679954
39.

Two-orthogonal-view method for quantification of rad dose to neck lesions in thyroid cancer therapy patients.

Koral KF, Adler RS, Carey JE, Kline RC, Beierwaltes WH.

Med Phys. 1982 Jul-Aug;9(4):497-505. No abstract available.

40.

Mouse sperm motility affected by factors in the T/t complex.

Tessler S, Carey JE, Olds-Clarke P.

J Exp Zool. 1981 Aug;217(2):277-85.

PMID:
7288391
41.

Oxidative metabolism of spermatozoa from inbred and random bred mice.

Carey JE, Olds-Clarke P, Storey BT.

J Exp Zool. 1981 May;216(2):285-92.

PMID:
7241067
42.

Thyroid contamination from airborne I-131.

Carey JE Jr, Swanson DP.

J Nucl Med. 1979 Apr;20(4):362. No abstract available.

43.

Absorbed dose to the human adrenals from lodomethylnorcholesterol (I-131) "NP-59": concise communication.

Carey JE, Thrall JH, Freitas JE, Beierwaltes WH.

J Nucl Med. 1979 Jan;20(1):60-2.

44.

Rate of egg penetration in vitro accelerated by T/t locus in the mouse.

Olds-Clarke P, Carey JE.

J Exp Zool. 1978 Dec;206(3):323-31.

PMID:
581387
45.

Technical considerations in in vivo thyroid studies.

Keyes JW Jr, Thrall JH, Carey JE.

Semin Nucl Med. 1978 Jan;8(1):43-57. Review.

PMID:
345446
46.

Localization of 133Xe in liver during ventilation studies.

Carey JE, Purdy JM, Moses DC.

J Nucl Med. 1974 Dec;15(12):1179-81. No abstract available.

47.

Studies on the fractions of the venom of the sea snake Enhydrina schistosa.

CAREY JE, WRIGHT EA.

Aust J Exp Biol Med Sci. 1962 Oct;40:427-35. No abstract available.

PMID:
14018633
48.

The site of action of the venom of the sea snake Enhydrina schistosa.

CAREY JE, WRITHT EA.

Trans R Soc Trop Med Hyg. 1961 Mar;55:153-60. No abstract available.

PMID:
13690775
49.

Isolation of the neurotoxic component of the venom of the sea snake, Enhydrina schistosa.

CAREY JE, WRIGHT EA.

Nature. 1960 Jan 9;185:103-4. No abstract available.

PMID:
13807688
50.

The toxicity and immunological properties of some sea-snake venoms with particular reference to that of Enhydrina schistosa.

CAREY JE, WRIGHT EA.

Trans R Soc Trop Med Hyg. 1960 Jan;54:50-67. No abstract available.

PMID:
13807689

Supplemental Content

Loading ...
Support Center